Status:
RECRUITING
Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD
Lead Sponsor:
University of Southern California
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lung Non-Small Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This study will attempt to identify social facilitators and barriers to detection and treatment of non-small cell lung cancer in order to learn how a history of substance abuse or alcohol use impacts ...
Detailed Description
PRIMARY OBJECTIVE: I. To identify social facilitators and barriers to detection and treatment of NSCLC by interviewing a diverse group of patients at Keck, Los Angeles General Medical Center, and Nor...
Eligibility Criteria
Inclusion
- \* Adults ≥ 18 years of age
- Histopathologic or cytologic diagnosis of NSCLC
- Received or receiving curative intent treatment (e.g. surgery, radiation therapy, systemic therapy)
- History of alcohol use or substance use disorder (other than tobacco use disorder) within the past 10 years, predating the cancer diagnosis
- Ability to understand and the willingness to sign a written informed consent
- English or Spanish speaking. Due to need to conduct semi-structured interviews which can develop into free-flowing conversations we need both participant and interviewer to be fluent
Exclusion
- Patients with cognitive disability unable to maintain 30-60 minute conversation
Key Trial Info
Start Date :
September 29 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 12 2028
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT07186699
Start Date
September 29 2025
End Date
September 12 2028
Last Update
October 27 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Angeles General Medical Center
Los Angeles, California, United States, 90033
2
USC / Norris Comprehensive Cancer Center
Los Angeles, California, United States, 90033